Joseph P. Balint

Corporate Officer/Principal presso Etubics Corp.

Health Technology

Consumer Services

Profilo

Joseph P.
Balint is currently the Laboratory Director at Etubics Corp.
Previously, he worked at Cypress Bioscience, Inc. from 1982 to 1996, where he held the position of Director-Extracorporeal Products in 1989.
He obtained a doctorate degree from Rutgers State University of New Jersey.

Posizioni attive di Joseph P. Balint

Società	Posizione	Inizio
Etubics Corp. Etubics Corp. BiotechnologyHealth Technology Etubics Corp. develops commercial prophylactic vaccines and immunotherapy products. It offers proprietary immunization platform technology called the etubics platform that develops therapeutic vaccines for colon and breast cancers and preventative vaccines for H1N1 Influenza and HIV. The company was founded by Frank R. Jones in 2003 and is headquartered in Seattle, WA.	Corporate Officer/Principal	-

Tutte le posizioni attive di Joseph P. Balint

Precedenti posizioni note di Joseph P. Balint

Società	Posizione	Fine
Cypress Bioscience, Inc. Cypress Bioscience, Inc. BiotechnologyHealth Technology Cypress Bioscience, Inc. develops drug therapies for Functional Somatic Syndromes, rheumatoid conditions that often cause sufferers chronic pain. The company provides medicine for Fibromyalgia Syndrome, a condition marked by painful stiffness, headaches and fatigue that affects approximately 5% of the world's population. The company was founded in 1981 and is located in San Diego, CA.	Corporate Officer/Principal	01/01/1989

Vedi nel dettaglio l'esperienza di Joseph P. Balint

Formazione di Joseph P. Balint

Rutgers State University of New Jersey

Doctorate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Joseph P. Balint

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Aziende private	2
Etubics Corp. Etubics Corp. BiotechnologyHealth Technology Etubics Corp. develops commercial prophylactic vaccines and immunotherapy products. It offers proprietary immunization platform technology called the etubics platform that develops therapeutic vaccines for colon and breast cancers and preventative vaccines for H1N1 Influenza and HIV. The company was founded by Frank R. Jones in 2003 and is headquartered in Seattle, WA.	Health Technology
Cypress Bioscience, Inc. Cypress Bioscience, Inc. BiotechnologyHealth Technology Cypress Bioscience, Inc. develops drug therapies for Functional Somatic Syndromes, rheumatoid conditions that often cause sufferers chronic pain. The company provides medicine for Fibromyalgia Syndrome, a condition marked by painful stiffness, headaches and fatigue that affects approximately 5% of the world's population. The company was founded in 1981 and is located in San Diego, CA.	Health Technology